HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $4
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has maintained a 'Buy' rating on Applied DNA Sciences (NASDAQ:APDN) but lowered the price target from $5 to $4.

August 14, 2023 | 10:43 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Applied DNA Sciences' price target has been lowered from $5 to $4 by HC Wainwright & Co., though the 'Buy' rating is maintained.
The lowering of the price target could potentially indicate a less optimistic outlook for the company's stock. However, the maintained 'Buy' rating suggests that the analyst still sees potential upside, which could balance out any negative impact from the lowered target.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100